Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
4
50%
Ph not_applicable
1
13%
Ph phase_3
3
38%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
4(50.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(2)
Other(6)

Detailed Status

unknown6
Completed2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (37.5%)
Phase 44 (50.0%)
N/A1 (12.5%)

Trials by Status

completed225%
unknown675%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8